These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3004800)

  • 1. Alopecia associated with long-term metyrapone use.
    Harris PL
    Clin Pharm; 1986 Jan; 5(1):66-8. PubMed ID: 3004800
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.
    Yoshida M; Umeda H; Iwama S; Nakayama S; Miyata M; Ogawa K; Maeda H; Oiso Y
    Endocrine; 2012 Feb; 41(1):160-1. PubMed ID: 22038492
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful control of Cushing's disease in the elderly with long term metyrapone.
    Donckier J; Burrin JM; Ramsay ID; Joplin GF
    Postgrad Med J; 1986 Aug; 62(730):727-30. PubMed ID: 3022270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metyrapone in long-term management of Cushing's disease.
    Jeffcoate WJ; Rees LH; Tomlin S; Jones AE; Edwards CR; Besser GM
    Br Med J; 1977 Jul; 2(6081):215-7. PubMed ID: 195666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metyrapone for Cushing's syndrome.
    Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
    Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR; Ross W; Hall R; Cook DB
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
    Vong CH; Forest M; Nicolino M
    J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful metyrapone therapy of the ectopic ACTH syndrome.
    Coll R; Horner I; Kraiem Z; Gafni J
    Arch Intern Med; 1968 Jun; 121(6):549-53. PubMed ID: 4297368
    [No Abstract]   [Full Text] [Related]  

  • 10. Unexpected adverse effect of metyrapone: A case report.
    Rouland A; Nguyen A; Fourmont C; Lapray M; Vergès B; Petit JM; Bouillet B
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):112-113. PubMed ID: 29672894
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metyrapone is useful only as adjunctive therapy in Cushing's disease.
    Orth DN
    Ann Intern Med; 1978 Jul; 89(1):128-30. PubMed ID: 208445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cushing's syndrome].
    Shimizu N; Kato T
    Naika; 1971 Jun; 27(6):1202-6. PubMed ID: 4326410
    [No Abstract]   [Full Text] [Related]  

  • 14. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
    Kellner M; Otte C; Yassouridis A; Schick M; Jahn H; Wiedemann K
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):337-9. PubMed ID: 15163445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metyrapone-induced alopecia.
    Harries-Jones R; Overstall P
    Postgrad Med J; 1990 Jul; 66(777):584. PubMed ID: 2217026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Medical therapy of hyperadrenalism].
    Raith L
    Minerva Med; 1973 Mar; 64(14):682-4. PubMed ID: 4350585
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome with dual pituitary-adrenal control.
    Choi Y; Werk EE; Sholiton LJ
    Arch Intern Med; 1970 Jun; 125(6):1045-9. PubMed ID: 4378134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Silvestrini F; D'Alonzo R
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1680-4. PubMed ID: 4335210
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
    Gogel EL; Salber PR; Tyrrell JB; Rosenblum ML; Findling JW
    Arch Intern Med; 1983 May; 143(5):1040-2. PubMed ID: 6089681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel medical treatment of pituitary adrenocorticotropic hormone-dependent hypercortisolism: a case study.
    Vlad LD; Alzahrani SA
    Endocr Pract; 2010; 16(6):1073-4. PubMed ID: 21216724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.